Pharmacogenetics

Results: 197



#Item
71Pharmacy / Alcohols / Cytochrome P450 / AstraZeneca / Omeprazole / Prasugrel / CYP2D6 / Metoprolol / Clopidogrel / Chemistry / Organic chemistry / Pharmacology

Implementing Pharmacogenetics in Community Pharmacy Theresa Tolle, BPharm, FAPhA Pharmacist/ Owner Bay Street Pharmacy Brian Hocum, PharmD Genelex Corporation

Add to Reading List

Source URL: www.pqaalliance.org

Language: English - Date: 2013-05-22 10:03:45
72Hepatitis / Medicine / Microbiology / Viruses / Pharmacogenetics / Peginterferon alfa-2a / Hepatitis C virus / Hepatitis C / Health

What is IL28B? Our bodies are made up of many different types of chemicals that make us who we a re — t h e se a re called genes. Genes can

Add to Reading List

Source URL: www.hcvadvocate.org

Language: English - Date: 2014-09-18 02:04:12
73Genomics / Pharmacy / Pharmacogenetics / Personalized medicine / Cytochrome P450 / CYP2D6 / Irinotecan / Food and Drug Administration / Toxicology / Pharmaceutical sciences / Pharmacology / Biology

Toxicology Diagnostic Device Update FDA Advisory Panel Meeting December 6, 2006 Courtney C. Harper, Ph.D. Associate Director for Toxicology

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-12-14 10:44:35
74Pharmacy / Beta blockers / Alcohols / Ethers / CYP2D6 / Metoprolol / Pharmacogenomics / Pharmacogenetics / Dextromethorphan / Pharmacology / Chemistry / Pharmaceutical sciences

A Meta-Analysis of CYP2D6 Metabolizer Phenotype and Metoprolol Pharmacokinetics

Add to Reading List

Source URL: biomed.health.umt.edu

Language: English - Date: 2013-10-10 16:53:38
75AstraZeneca / Chemistry / Alkenes / Prodrugs / Tamoxifen / Treatment of bipolar disorder / Pharmacogenetics / CYP2D6 / Aromatase inhibitor / Pharmacology / Medicine / Selective estrogen receptor modulators

Bibliography of publications included in the backgrounder

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-09-28 09:40:14
76Pharmacy / Health / Biology / Genetics / National Institutes of Health / Personalized medicine / National Institute of General Medical Sciences / Pharmacogenetics / National Heart /  Lung /  and Blood Institute / Medicine / Genomics / Pharmacology

November 11, 2008 The Center for Genomic Medicine Announces Five New Collaborative Projects with the U.S. National Institute of Health (NIH) Groups

Add to Reading List

Source URL: www.riken.jp

Language: English - Date: 2013-05-14 04:50:02
77Bioinformatics / Pharmacy / Pharmacology / Molecular biology / Single-nucleotide polymorphism / Pharmacogenomics / Genotyping / Human genome / Pharmacogenetics / Biology / Genetics / Genomics

© 2000 Nature America Inc. • http://biotech.nature.com TECHNOLOGIES Pharmacogenomics

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2012-12-20 10:18:32
78Irinotecan / Lactams / Lactones / Piperidines / Health / Organic chemistry / UDP glucuronosyltransferase 1 family /  polypeptide A1 / SN-38 / Pharmacogenetics / Medicine / Pharmacy / Prodrugs

Topic 1. Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism Camptosar (Irinotecan hydrochloride injection) received accelerated approval on June 14, 1996 for the treatment of patients with

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-10-14 14:44:53
79Clinical trials / Epidemiology / Medical research / Medical terms / Prodrugs / Biomarker / Irinotecan / Surrogate endpoint / CYP3A4 / Medicine / Chemistry / Health

Topic 1 Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism 1. Is the pharmacokinetic and clinical evidence presented sufficient to demonstrate that homozygous UGT1A1*28 genotypes (7/7 ge

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-10-14 14:44:52
80Pharmacokinetics / Drug discovery / Pharmaceutical industry / Clinical trial / Clinical pharmacology / Pharmacodynamics / Food and Drug Administration / Pharmacogenetics / Therapeutic drug monitoring / Pharmaceutical sciences / Pharmacology / Pharmacy

The magnitude of personal financial interest: $0 - $10,000 per year Description of the Particular Matter to Which the Waiver Applies: The committee will discuss the clinical pharmacology aspects of pediatric clinical tr

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE